BE902642A - ARYL-10 DIHYDROXY-1,8 ANTRHONES AND THEIR ESTERS, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS. - Google Patents

ARYL-10 DIHYDROXY-1,8 ANTRHONES AND THEIR ESTERS, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS.

Info

Publication number
BE902642A
BE902642A BE0/215174A BE215174A BE902642A BE 902642 A BE902642 A BE 902642A BE 0/215174 A BE0/215174 A BE 0/215174A BE 215174 A BE215174 A BE 215174A BE 902642 A BE902642 A BE 902642A
Authority
BE
Belgium
Prior art keywords
dihydroxy
aryl
human
veterinary medicine
antrhones
Prior art date
Application number
BE0/215174A
Other languages
French (fr)
Inventor
B Shroot
G Lang
J Maignan
S Restle
Original Assignee
Galderma Rech Dermatologique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Rech Dermatologique filed Critical Galderma Rech Dermatologique
Publication of BE902642A publication Critical patent/BE902642A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/4211,3-Oxazoles, e.g. pemoline, trimethadione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/737Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Aryl-10 dihydroxy-1,8 anthrone de la formule générale I dans laquelle Ar represente un reste aromatique, substitué ou non et les substituants étant H, <hal, Cf3, OH, Alk, alcoxy, nitrile SO2NR1R2, divers heterocycles, ou autres utilisations en médecine humaine ou vétérinaire dans le traitement des tumeurs cancéreuses, du psoriasis, des verrues, eczéma et autres.Aryl-10 dihydroxy-1,8 anthrone of the general formula I in which Ar represents an aromatic residue, substituted or not and the substituents being H, <hal, Cf3, OH, Alk, alkoxy, nitrile SO2NR1R2, various heterocycles, or others uses in human or veterinary medicine in the treatment of cancerous tumors, psoriasis, warts, eczema and others.

BE0/215174A 1984-06-13 1985-06-12 ARYL-10 DIHYDROXY-1,8 ANTRHONES AND THEIR ESTERS, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS. BE902642A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8409203A FR2565966B1 (en) 1984-06-13 1984-06-13 ARYL-10 DIHYDROXY-1,8 ANTHRONES AND THEIR ESTERS, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS

Publications (1)

Publication Number Publication Date
BE902642A true BE902642A (en) 1985-12-12

Family

ID=9304944

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/215174A BE902642A (en) 1984-06-13 1985-06-12 ARYL-10 DIHYDROXY-1,8 ANTRHONES AND THEIR ESTERS, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS.

Country Status (11)

Country Link
JP (1) JPS6140238A (en)
BE (1) BE902642A (en)
CA (1) CA1253859A (en)
CH (1) CH664557A5 (en)
DE (1) DE3521074A1 (en)
DK (1) DK265185A (en)
FR (1) FR2565966B1 (en)
GB (1) GB2160864B (en)
IT (1) IT1190365B (en)
NL (1) NL8501699A (en)
SE (1) SE459807B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843097A (en) * 1984-06-13 1989-06-27 Groupement D'interet Economique Dit: Centre International De Recherches Dermatologiques C.I.R.D. 10-aryl-1,8-dihydroxy-9-anthrones and their esters, process for preparing same, and use of same in human and veterinary medicine and in cosmetics
DE4231636A1 (en) * 1992-09-22 1994-03-24 Beiersdorf Ag New anthrone and anthracene derivatives substituted in the 10-position, processes for their preparation, pharmaceutical or cosmetic compositions containing these compounds and their use
US5426197A (en) * 1993-07-19 1995-06-20 Teva Pharmaceutical Industries, Ltd. 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31289A (en) * 1968-01-08 1974-01-14 Ciba Geigy Ag Pharmaceutical preparation containing a dermatologically active difluorinated corticoid and dithranol
DE2154608A1 (en) * 1970-11-12 1972-06-29 Ciba-Geigy Ag, Basel (Schweiz) New diacetate, pharmaceutical preparations and manufacturing processes
DE3002089A1 (en) * 1980-01-22 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach NEW, SUBSTITUTED 1,8-DIHYDROXY-9- (10H) -ANTHRACENONE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
FR2492372A1 (en) * 1980-10-21 1982-04-23 Cird 1,8-DIHYDROXY-9-ANTHRONES SUBSTITUTED IN POSITION 10 AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS
FR2495934A1 (en) * 1980-12-15 1982-06-18 Cird COMPOSITION FOR THE TREATMENT OF PSORIASIS BASED ON SUBSTITUTED-1,8-DIHYDROXY-1,8-ANTHRONE-9

Also Published As

Publication number Publication date
IT8521130A0 (en) 1985-06-12
GB2160864B (en) 1987-12-31
FR2565966B1 (en) 1986-08-29
IT1190365B (en) 1988-02-16
DK265185D0 (en) 1985-06-12
CA1253859A (en) 1989-05-09
NL8501699A (en) 1986-01-02
DE3521074A1 (en) 1985-12-19
JPS6140238A (en) 1986-02-26
CH664557A5 (en) 1988-03-15
GB2160864A (en) 1986-01-02
FR2565966A1 (en) 1985-12-20
SE459807B (en) 1989-08-07
SE8502910L (en) 1985-12-14
GB8514973D0 (en) 1985-07-17
SE8502910D0 (en) 1985-06-12
DK265185A (en) 1985-12-14

Similar Documents

Publication Publication Date Title
DE3568272D1 (en) 4-vinylbenzoic-acid derivatives, their preparation and their use as therapeutical compositions and as ligands
BE904421A (en) AROMATIC HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN THE THERAPEUTIC AND COSMETIC FIELDS.
NL300209I2 (en) Benzonaphthalene derivatives, process for their preparation and their use in the pharmaceutical and cosmetic field.
FR2417500A1 (en) DERIVATIVES OF CYCLIC DEHYDROGENIC AMINO ACIDS AND THEIR THERAPEUTIC USE
HUP9600448A2 (en) Naphthyl compounds, pharmaceutical compositions containing them, process for producing them, their intermediates and their use
ATE243525T1 (en) PREPARATIONS OF IMMUNOGENIC MOLECULES CONTAINING GRANULOCYTE-MACROPAGE STIMULATING FACTOR AS ADJUVANT
FR2417510A1 (en) 9-AMINO- AND IMINO-DIBENZOPYRANS AND THEIR THERAPEUTIC USE
FR2358138A1 (en) COSMETIC PRODUCTS CONTAINING HYDROXYALCANE-CARBOXYLIC ACID AMIDS AS MOISTURIZING AGENTS FOR THE SKIN
ES460098A1 (en) Derivatives of penicillanic acid
JPS5699412A (en) Rosemary aciddcontaining pharmaceutic product
FR2430409A1 (en) PHENETHANOLAMINES AND THEIR USE AS POTENTIALIZERS FOR CANCER CELL DESTRUCTIVE DRUGS
FR2415630A1 (en) NEW 5-VINYL-2-PYRROLIDONES, USEFUL IN PARTICULAR IN THE PREPARATION OF 4-AMINO-5-HEXENOIC AND 4-AMINO-5-HEXYNOIC ACIDS, AND THEIR PREPARATION
IE35375B1 (en) Tetrahydronaphthyloxyaminopropanols and related compounds
FR2417502A1 (en) NEW SUBSTITUTED 2-PHENYLIMINO-IMIDAZOLIDINES, THEIR ADDITIONAL SALTS WITH ACIDS, MEDICINAL PRODUCTS CONTAINING THEM AND METHODS FOR THEIR PREPARATION
BE902642A (en) ARYL-10 DIHYDROXY-1,8 ANTRHONES AND THEIR ESTERS, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS.
FR2375245A1 (en) CARBOXYPHOSPHONIC ACIDS USABLE FOR WATER TREATMENT
FR2442852A1 (en) NEW PENICILLINS AND THEIR APPLICATION IN THERAPEUTICS
FR2359153A1 (en) NEW CARBOXYL ESTERS OF PHOSPHONOACETIC ACID USEFUL IN PARTICULAR FOR THE TREATMENT OF SIMPLEX HERPICAL INFECTIONS
MA19952A1 (en) NOVEL NITROSOUREE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP2742982B2 (en) Active oxygen scavenger
FR2383176A1 (en) AMINO ARYL TRIAZINES 1-2-4 FOR USE IN THE TREATMENT OF MISCELLANEOUS ALGIA
FR2421613A1 (en) COMPOSITIONS CONTAINING 3-AMINOPYRROLIDINE BENZAMIDES AND THEIR THERAPEUTIC USE FOR THE TREATMENT OF ALLERGIES
ES426040A1 (en) Vinvamine series cycloalkyl-alkyl esters
FR2380778A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTE OXANILIC ACIDS OR THEIR ESTERS
Roe Effect of phenanthrene on tumour-initiation by 3, 4-benzopyrene

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES

Effective date: 19930630